Related Experiment Video
Updated: Oct 27, 2025

08:55
In vitro Transcription and Capping of Gaussia Luciferase mRNA Followed by HeLa Cell Transfection
Published on: March 26, 2012
18.5K
Enzymatic Assays to Explore Viral mRNA Capping Machinery
Renata Kasprzyk1,2, Jacek Jemielity1
1Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097, Warsaw, Poland.
Chembiochem : a European Journal of Chemical Biology
|July 22, 2021
Summary
This review covers methods to screen compounds targeting viral mRNA capping enzymes. These enzymes are crucial for viral replication and host immune evasion, offering potential for antiviral drug discovery.
Area of Science:
- Molecular Biology
- Virology
- Drug Discovery
Background:
- Eukaryotic mRNA requires 7-methylguanosine (m7G) 5' capping for stability and translation.
- Viruses utilize distinct mRNA capping pathways to enhance protein expression and evade host immunity.
- Understanding viral capping mechanisms is vital for developing antivirals against pandemic threats like coronaviruses.
Purpose of the Study:
- To review methods for monitoring mRNA capping enzyme activity.
- To highlight techniques for screening inhibitors of viral mRNA capping enzymes.
- To support rational antiviral drug design targeting viral replication.
Main Methods:
- Summarizes various assays for assessing mRNA capping enzyme kinetics.
- Discusses high-throughput screening (HTS) approaches for compound libraries.
- Covers methods to evaluate enzyme inhibition and antiviral potential.
Main Results:
- Provides an overview of established and emerging techniques for studying mRNA capping.
- Identifies key enzymes in the viral mRNA capping pathway as drug targets.
- Emphasizes the need for robust screening methods to identify novel antiviral leads.
Conclusions:
- Effective screening methods are essential for identifying inhibitors of viral mRNA capping enzymes.
- Targeting viral mRNA capping presents a promising strategy for antiviral drug development.
- This review facilitates the discovery of new therapeutics against RNA viruses.

